West Nyack, NY, United States of America

Bhaskar C Das

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Overland Park, KS (US) (2019)
West Nyack, NY (US) (2013 - 2023)
Kansas City, KS (US) (2016 - 2023)

Company Filing History:

7 out of 504

Albert Einstein College of Medicine

patents

4 out of 817

Louisiana State University and Agricultural & Mechanical College

patents

3 out of 270

Icahn School of Medicine at Mount Sinai

The United States Government As Represented by the Department of Veterans Affairs

patents

6. 2 out of 1,993

The State University of New York

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12269803 - Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease (2025-04-08),

2. 11643394 - Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease (2023-05-09),

3. 11591324 - Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof (2023-02-28),

4. 10766886 - Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof (2020-09-08),

5. 10669266 - Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis (2020-06-02),

6. 10450305 - LKB1-AMPK activators for therapeutic use in polycystic kidney disease (2019-10-22),

7. 10189827 - Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof (2019-01-29),

8. 10174012 - LKB1-AMPK activators for therapeutic use in polycystic kidney disease (2019-01-08),

9. 10047107 - Small molecule analogs of E4orf1 (2018-08-14),

10. 9714259 - Compositions and methods for improving glucose uptake (2017-07-25),

11. 9512092 - Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof (2016-12-06),

12. 9469659 - Compositions and methods for improving glucose uptake (2016-10-18),

13. 9346835 - Compositions and methods for improving glucose uptake (2016-05-24),

14. 8669260 - Ketoconazole-derivative antagonist of human pregnane X receptor and uses thereof (2014-03-11),

15. 8581005 - Mitochondrial inhibitors to treat human disease (2013-11-12),

Title: **Inventor Bhaskar C Das: Innovations in Kidney Disease Treatment**

Introduction

Bhaskar C Das, a prominent inventor based in West Nyack, NY, has made significant contributions to the field of medical research and innovation. With a remarkable portfolio of 16 patents, his work primarily focuses on small molecule modulators that have the potential to transform the treatment of serious health disorders.

Latest Patents

One of Bhaskar C Das's notable recent inventions is related to "Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease." This patent emphasizes the development of small molecule modulators of KLF15 signaling, which are aimed at treating various disorders, such as chronic kidney disease, heart disease, obesity, and neurodegenerative disorders including amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and more. The invention seeks to address critical health challenges and represents a significant advancement in therapeutic strategies.

Career Highlights

Throughout his career, Bhaskar C Das has had the opportunity to work with esteemed institutions. He has held positions at the Albert Einstein College of Medicine and Louisiana State University and Agricultural & Mechanical College, which have provided him with a solid platform for his innovative research and development.

Collaborations

Collaboration has been a cornerstone of Bhaskar C Das's research endeavors. Notable colleagues such as Ana Maria Cuervo and Evripidis Gavathiotis have worked alongside him, contributing to his efforts in advancing medical science and patent development. These partnerships highlight the importance of teamwork in fostering innovation.

Conclusion

Bhaskar C Das continues to make strides in the field of medical innovations, particularly in the treatment of kidney disease and related disorders. His patents not only reflect his expertise and dedication but also inspire future advancements in healthcare solutions. As his work continues to evolve, the impact of his inventions promises to enhance patient outcomes and deepen our understanding of critical health issues.

This text is generated by artificial intelligence and may not be accurate.